Study on Fractionated Gemtuzumab Ozogamicin for Treating Residual Disease in Acute Myeloid Leukemia Patients | Clinical Trial

Study on Fractionated Gemtuzumab Ozogamicin for Treating Residual Disease in Acute Myeloid Leukemia Patients | Clinical Trial | Right2Hope